Hsa_circ_0032463 acts as the tumor promoter in osteosarcoma by regulating the miR‑330‑3p/PNN axis

Guanghua Qin1, Xuejian Wu1

  • 1Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, P.R. China.

Insights

Circular RNA circ_0032463 promotes osteosarcoma (OS) progression by enhancing cell proliferation and invasion. This bone cancer-associated circular RNA inhibits miR-330-3p, leading to increased PNN expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma (OS) remains a significant health concern, particularly for adolescents, with unclear etiological factors.
  • Despite research efforts, effective treatments for OS are limited, necessitating further investigation into its underlying mechanisms.

Purpose of the Study:

  • To investigate the role of circular RNA circ_0032463 in the progression of osteosarcoma.
  • To elucidate the molecular mechanisms involving circ_0032463, microRNA (miR)-330-3p, and Pinin desmosome associated protein (PNN) in OS.

Main Methods:

  • Quantitative PCR to assess circ_0032463 expression.
  • Cellular assays (BrdU, CCK-8, flow cytometry, Transwell, adhesion) to evaluate OS cell behavior.
  • Molecular techniques (RNA pull-down, RIP, dual-luciferase) to determine interactions between circ_0032463, miR-330-3p, and PNN.

Main Results:

  • Circ_0032463 and PNN were upregulated in OS tissues and cell lines.
  • Circ_0032463 promoted OS cell proliferation, viability, invasion, and adhesion while inhibiting apoptosis.
  • miR-330-3p expression was inversely correlated with OS progression.
  • Circ_0032463 was found to directly inhibit miR-330-3p, consequently upregulating PNN expression.

Conclusions:

  • Circ_0032463 acts as a tumor promoter in osteosarcoma.
  • The circ_0032463/miR-330-3p/PNN axis plays a crucial role in OS development and progression.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K